Comments
Loading...

Immunocore Holdings Analyst Ratings

IMCRNASDAQ
Logo brought to you by Benzinga Data
$29.04
-0.39-1.33%
At close: -
$29.04
0.000.00%
After Hours: 4:00 PM EDT
Consensus Rating1
Outperform
Highest Price Target1
$100.00
Lowest Price Target1
$24.00
Consensus Price Target1
$71.00

Immunocore Holdings Analyst Ratings and Price Targets | NASDAQ:IMCR | Benzinga

Immunocore Holdings PLC has a consensus price target of $71 based on the ratings of 19 analysts. The high is $100 issued by HC Wainwright & Co. on March 12, 2025. The low is $24 issued by UBS on October 24, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Needham, and Morgan Stanley on March 12, 2025, March 12, 2025, and March 7, 2025, respectively. With an average price target of $68.67 between HC Wainwright & Co., Needham, and Morgan Stanley, there's an implied 136.46% upside for Immunocore Holdings PLC from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Dec 24
2
Jan
2
Feb
3
1
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.9
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Needham
Morgan Stanley
Mizuho
UBS

1calculated from analyst ratings

Analyst Ratings for Immunocore Holdings

Buy NowGet Alert
03/12/2025Buy Now244.35%HC Wainwright & Co.
Patrick Trucchio43%
$100 → $100ReiteratesBuy → BuyGet Alert
03/12/2025Buy Now144.49%Needham
Gil Blum48%
$71 → $71ReiteratesBuy → BuyGet Alert
03/07/2025Buy Now20.52%Morgan Stanley
Andrew Galler33%
$35 → $35Assumes → Equal-WeightGet Alert
03/05/2025Buy Now244.35%HC Wainwright & Co.
Patrick Trucchio43%
$100 → $100ReiteratesBuy → BuyGet Alert
02/28/2025Buy Now244.35%HC Wainwright & Co.
Patrick Trucchio43%
$100 → $100ReiteratesBuy → BuyGet Alert
02/27/2025Buy Now144.49%Needham
Gil Blum48%
$71 → $71ReiteratesBuy → BuyGet Alert
01/27/2025Buy Now244.35%HC Wainwright & Co.
Patrick Trucchio43%
$100 → $100ReiteratesBuy → BuyGet Alert
01/10/2025Buy Now144.49%Needham
Gil Blum48%
$71 → $71ReiteratesBuy → BuyGet Alert
12/13/2024Buy Now20.52%Morgan Stanley
Andrew Galler33%
$74 → $35DowngradeOverweight → Equal-WeightGet Alert
11/11/2024Buy Now30.85%Mizuho
Graig Suvannavejh54%
$72 → $38DowngradeOutperform → NeutralGet Alert
11/07/2024Buy Now144.49%Needham
Gil Blum48%
$78 → $71MaintainsBuyGet Alert
10/24/2024Buy Now-17.36%UBS
David Dai26%
→ $24Initiates → SellGet Alert
10/24/2024Buy Now244.35%HC Wainwright & Co.
Patrick Trucchio43%
$100 → $100ReiteratesBuy → BuyGet Alert
10/11/2024Buy Now154.82%Morgan Stanley
Andrew Galler33%
$80 → $74MaintainsOverweightGet Alert
10/07/2024Buy Now—Guggenheim
Michael Schmidt51%
—DowngradeBuy → NeutralGet Alert
09/17/2024Buy Now244.35%HC Wainwright & Co.
Patrick Trucchio43%
$100 → $100ReiteratesBuy → BuyGet Alert
09/17/2024Buy Now168.6%Needham
Gil Blum48%
$81 → $78MaintainsBuyGet Alert
09/09/2024Buy Now—Cantor Fitzgerald
Eric Schmidt30%
—Reiterates → OverweightGet Alert
08/28/2024Buy Now244.35%HC Wainwright & Co.
Patrick Trucchio43%
$100 → $100ReiteratesBuy → BuyGet Alert
08/09/2024Buy Now206.47%Oppenheimer
Jeff Jones32%
$87 → $89ReiteratesOutperform → OutperformGet Alert
08/09/2024Buy Now127.27%Barclays
Peter Lawson41%
$92 → $66MaintainsOverweightGet Alert
08/09/2024Buy Now178.93%Needham
Gil Blum48%
$81 → $81ReiteratesBuy → BuyGet Alert
07/10/2024Buy Now127.27%JP Morgan
Jessica Fye67%
$70 → $66MaintainsOverweightGet Alert
06/05/2024Buy Now244.35%HC Wainwright & Co.
Patrick Trucchio43%
$100 → $100ReiteratesBuy → BuyGet Alert
06/03/2024Buy Now178.93%Needham
Gil Blum48%
$81 → $81ReiteratesBuy → BuyGet Alert
05/30/2024Buy Now244.35%HC Wainwright & Co.
Patrick Trucchio43%
$100 → $100ReiteratesBuy → BuyGet Alert
05/29/2024Buy Now178.93%Needham
Gil Blum48%
$81 → $81ReiteratesBuy → BuyGet Alert
05/24/2024Buy Now244.35%HC Wainwright & Co.
Patrick Trucchio43%
$100 → $100ReiteratesBuy → BuyGet Alert
05/24/2024Buy Now178.93%Needham
Gil Blum48%
$81 → $81ReiteratesBuy → BuyGet Alert
05/13/2024Buy Now203.03%Mizuho
Graig Suvannavejh54%
$90 → $88MaintainsBuyGet Alert
05/09/2024Buy Now130.72%Canaccord Genuity
Bill Maughan19%
$63 → $67MaintainsHoldGet Alert
05/09/2024Buy Now244.35%HC Wainwright & Co.
Patrick Trucchio43%
$90 → $100MaintainsBuyGet Alert
05/09/2024Buy Now178.93%Needham
Gil Blum48%
→ $81ReiteratesBuy → BuyGet Alert
04/29/2024Buy Now154.82%Leerink Partners
Jonathan Chang38%
→ $74Initiates → OutperformGet Alert
04/23/2024Buy Now216.8%Guggenheim
Michael Schmidt51%
$92 → $92ReiteratesBuy → BuyGet Alert
04/11/2024Buy Now178.93%Needham
Gil Blum48%
$81 → $81ReiteratesBuy → BuyGet Alert
03/20/2024Buy Now141.05%JP Morgan
Jessica Fye67%
$60 → $70MaintainsOverweightGet Alert
03/06/2024Buy Now209.92%HC Wainwright & Co.
Patrick Trucchio43%
$90 → $90ReiteratesBuy → BuyGet Alert
03/05/2024Buy Now209.92%Mizuho
Graig Suvannavejh54%
$86 → $90MaintainsBuyGet Alert
02/29/2024Buy Now199.59%Oppenheimer
Justin Kim37%
$85 → $87ReiteratesOutperform → OutperformGet Alert
02/29/2024Buy Now116.94%Canaccord Genuity
Bill Maughan19%
$60 → $63MaintainsHoldGet Alert
02/29/2024Buy Now178.93%Needham
Gil Blum48%
→ $81ReiteratesBuy → BuyGet Alert
02/16/2024Buy Now196.14%Mizuho
Graig Suvannavejh54%
$72 → $86MaintainsBuyGet Alert
11/20/2023Buy Now106.61%JP Morgan
Jessica Fye67%
→ $60Reinstates → OverweightGet Alert
11/02/2023Buy Now—Cantor Fitzgerald
Eric Schmidt30%
—Initiates → OverweightGet Alert
10/31/2023Buy Now189.26%Baird
Jack Allen 36%
→ $84Initiates → OutperformGet Alert
09/21/2023Buy Now192.7%Oppenheimer
Justin Kim37%
$75 → $85MaintainsOutperformGet Alert
09/13/2023Buy Now158.26%Needham
Gil Blum48%
→ $75Initiates → BuyGet Alert
08/23/2023Buy Now209.92%HC Wainwright & Co.
Patrick Trucchio43%
→ $90ReiteratesBuy → BuyGet Alert
08/16/2023Buy Now189.26%Capital One
Naureen Quibria19%
→ $84Initiates → OverweightGet Alert
08/11/2023Buy Now213.36%BTIG
Justin Zelin41%
$85 → $91MaintainsBuyGet Alert
08/11/2023Buy Now158.26%Oppenheimer
Justin Kim37%
$72 → $75MaintainsOutperformGet Alert
08/11/2023Buy Now209.92%HC Wainwright & Co.
Patrick Trucchio43%
→ $90ReiteratesBuy → BuyGet Alert
08/01/2023Buy Now172.04%Morgan Stanley
Andrew Galler33%
$79 → $79ReiteratesOverweight → OverweightGet Alert
07/31/2023Buy Now172.04%Morgan Stanley
Andrew Galler33%
$79 → $79ReiteratesOverweight → OverweightGet Alert
07/24/2023Buy Now172.04%Morgan Stanley
Andrew Galler33%
$79 → $79ReiteratesOverweight → OverweightGet Alert
07/17/2023Buy Now172.04%Morgan Stanley
Andrew Galler33%
$79 → $79ReiteratesOverweight → OverweightGet Alert
07/17/2023Buy Now130.72%Canaccord Genuity
Bill Maughan19%
→ $67Initiates → HoldGet Alert
07/11/2023Buy Now172.04%Morgan Stanley
Andrew Galler33%
$79 → $79ReiteratesOverweight → OverweightGet Alert
06/26/2023Buy Now172.04%Morgan Stanley
Andrew Galler33%
$79 → $79ReiteratesOverweight → OverweightGet Alert
06/20/2023Buy Now172.04%Goldman Sachs
Rajan Sharma26%
→ $79Reiterates → OverweightGet Alert
06/12/2023Buy Now172.04%Morgan Stanley
Andrew Galler33%
→ $79Reiterates → OverweightGet Alert
05/12/2023Buy Now209.92%HC Wainwright & Co.
Patrick Trucchio43%
→ $90ReiteratesBuy → BuyGet Alert
05/11/2023Buy Now154.82%Mizuho
Graig Suvannavejh54%
$70 → $74MaintainsBuyGet Alert
05/09/2023Buy Now209.92%HC Wainwright & Co.
Patrick Trucchio43%
→ $90Reiterates → BuyGet Alert
04/19/2023Buy Now209.92%HC Wainwright & Co.
Patrick Trucchio43%
→ $90Reiterates → BuyGet Alert
03/31/2023Buy Now141.05%Mizuho
Graig Suvannavejh54%
→ $70Initiates → BuyGet Alert
03/30/2023Buy Now192.7%Guggenheim
Michael Schmidt51%
→ $85Initiates → BuyGet Alert
03/08/2023Buy Now209.92%HC Wainwright & Co.
Patrick Trucchio43%
→ $90Reiterates → BuyGet Alert
02/15/2023Buy Now147.93%Oppenheimer
Justin Kim37%
$65 → $72MaintainsOutperformGet Alert
12/16/2022Buy Now—Goldman Sachs
Rajan Sharma26%
—UpgradeNeutral → BuyGet Alert
11/30/2022Buy Now175.48%Barclays
Peter Lawson41%
→ $80Initiates → OverweightGet Alert
11/21/2022Buy Now209.92%HC Wainwright & Co.
Patrick Trucchio43%
$80 → $90MaintainsBuyGet Alert
11/10/2022Buy Now172.04%Morgan Stanley
Andrew Galler33%
$72 → $79MaintainsOverweightGet Alert
10/13/2022Buy Now147.93%Morgan Stanley
Andrew Galler33%
$77 → $72MaintainsOverweightGet Alert
09/14/2022Buy Now130.72%JP Morgan
Jessica Fye67%
$60 → $67MaintainsOverweightGet Alert
09/09/2022Buy Now165.15%Morgan Stanley
Andrew Galler33%
→ $77Initiates → OverweightGet Alert
09/08/2022Buy Now182.37%Ladenburg Thalmann
Ahu Demir18%
→ $82Initiates → BuyGet Alert
08/08/2022Buy Now141.05%Cowen & Co.
Tyler Van Buren46%
→ $70Initiates → OutperformGet Alert
08/02/2022Buy Now192.7%BTIG
Justin Zelin41%
→ $85Initiates → BuyGet Alert

FAQ

Q

What is the target price for Immunocore Holdings (IMCR) stock?

A

The latest price target for Immunocore Holdings (NASDAQ:IMCR) was reported by HC Wainwright & Co. on March 12, 2025. The analyst firm set a price target for $100.00 expecting IMCR to rise to within 12 months (a possible 244.35% upside). 36 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Immunocore Holdings (IMCR)?

A

The latest analyst rating for Immunocore Holdings (NASDAQ:IMCR) was provided by HC Wainwright & Co., and Immunocore Holdings reiterated their buy rating.

Q

When was the last upgrade for Immunocore Holdings (IMCR)?

A

The last upgrade for Immunocore Holdings PLC happened on December 16, 2022 when Goldman Sachs raised their price target to N/A. Goldman Sachs previously had a neutral for Immunocore Holdings PLC.

Q

When was the last downgrade for Immunocore Holdings (IMCR)?

A

The last downgrade for Immunocore Holdings PLC happened on December 13, 2024 when Morgan Stanley changed their price target from $74 to $35 for Immunocore Holdings PLC.

Q

When is the next analyst rating going to be posted or updated for Immunocore Holdings (IMCR)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Immunocore Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Immunocore Holdings was filed on March 12, 2025 so you should expect the next rating to be made available sometime around March 12, 2026.

Q

Is the Analyst Rating Immunocore Holdings (IMCR) correct?

A

While ratings are subjective and will change, the latest Immunocore Holdings (IMCR) rating was a reiterated with a price target of $100.00 to $100.00. The current price Immunocore Holdings (IMCR) is trading at is $29.04, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch